Rosman Yossi, Gabay Linoy, Landau Tami, Confino-Cohen Ronit
Allergy and Clinical Immunology Unit, Meir Medical Center, Kfar Saba, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
J Asthma Allergy. 2021 Nov 10;14:1367-1373. doi: 10.2147/JAA.S334560. eCollection 2021.
Childhood asthma is the most common chronic disease throughout the western world. Improving asthma control is a leading health management goal.
To evaluate the effect of an intervention by a visit to an asthma specialist on asthma control in children.
This retrospective study was conducted using the electronic database of Maccabi Health Services. All members ages 5-16 with an asthma diagnosis during 2000-2016, and at least one visit to a specialist were included. Asthma outcomes during the 2 years before and after the visit to the asthma specialist were compared.
A total of 37,066 children were diagnosed with asthma. Among them, 13,533 (36.5%) had at least one visit to an asthma specialist and were included. Children with asthma visited their primary care physician more often in the period before the specialist visit (4.4± 4.4 vs 3.16± 3.9 visits, respectively; p<0.01). After visiting a specialist, average number of visits to emergency departments (0.52± 1.3 vs 0.45±1), all cause hospitalizations (0.13±0.45 vs 0.08±0.4) and hospitalizations due to asthma exacerbations (0.08±0.345 vs 0.05±0.3) decreased (p<0.01 for all comparisons). Prescription of short-acting beta agonists decreased (2.85±3.6 vs 2.2 ±3.7, p<0.01) and inhaled steroid prescriptions increased (1.9±2.9 vs 2.7±3.7, p<0.01), respectively, after the intervention. A substantial reduction in the prescription of corticosteroids (0.81±1.9 vs 0.43±1.4, p<0.01) after specialist visit was also noted.
We found significant positive outcomes after a single consultation with an asthma specialist. Referring pediatric asthma patients to an asthma specialist should be one of the goals of an asthma management plan.
儿童哮喘是西方世界最常见的慢性病。改善哮喘控制是一项首要的健康管理目标。
评估拜访哮喘专科医生的干预措施对儿童哮喘控制的效果。
本回顾性研究使用了马卡比健康服务中心的电子数据库。纳入所有在2000年至2016年期间年龄在5至16岁、被诊断为哮喘且至少拜访过一次专科医生的成员。比较拜访哮喘专科医生前后两年的哮喘相关结果。
共有37,066名儿童被诊断为哮喘。其中,13,533名(36.5%)至少拜访过一次哮喘专科医生并被纳入研究。哮喘患儿在拜访专科医生之前的时期更频繁地拜访其初级保健医生(分别为4.4±4.4次和3.16±3.9次;p<0.01)。拜访专科医生后,急诊就诊的平均次数(0.52±1.3次对0.45±1次)、所有病因的住院次数(0.13±0.45次对0.08±0.4次)以及因哮喘加重导致的住院次数(0.08±0.345次对0.05±0.3次)均减少(所有比较的p<0.01)。干预后,短效β受体激动剂的处方量减少(2.85±3.6对2.2±3.7,p<0.01),吸入性糖皮质激素的处方量增加(1.9±2.9对2.7±3.7,p<0.01)。专科医生拜访后,糖皮质激素的处方量也大幅减少(0.81±1.9对0.43±1.4,p<0.01)。
我们发现与哮喘专科医生进行单次会诊后有显著的积极效果。将儿科哮喘患者转诊至哮喘专科医生应是哮喘管理计划的目标之一。